Physician profile
Bruce Henderson
NPI 1568460913
$2,347.18
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,402 · 2020: $578 · 2021: $367.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,194.72 | 2019-2021 | |
| Allergan, INC. | $288.71 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $283.78 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $114.68 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $108.88 | 2020-2021 | |
| Glaukos Corporation | $92.24 | 2020-2021 | |
| Sight Sciences, INC. | $63.52 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $52.22 | 2019-2021 | |
| Ivantis, INC | $47.10 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $27.89 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $24.46 | 2019 | |
| Shire North American Group INC | $18.40 | 2019 | |
| Horizon Therapeutics Plc | $16.40 | 2021 | |
| Carl Zeiss Meditec, INC. | $14.18 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.